<?xml version="1.0" encoding="UTF-8"?>
<p id="P10">Intravenous acyclovir is the first-line treatment for HSV encephalitis
 <sup>
  <xref ref-type="bibr" rid="R9">9</xref>
 </sup> and should be started as soon as the disease is suspected clinically. Magnetic resonance imaging of the brain typically demonstrates temporal lobe involvement, and diagnosis is confirmed by detection of HSV DNA in the CSF. Major studies have evaluated the efficacy of 10 days of acyclovir treatment for HSV encephalitis; however, the recommended duration of treatment in the clinical setting is 2 to 3 weeks because shorter durations have been associated with relapse.
 <sup>
  <xref ref-type="bibr" rid="R10">10</xref>
 </sup> The treatment duration may be further prolonged in immunocompromised patients.
 <sup>
  <xref ref-type="bibr" rid="R8">8</xref>
 </sup>
</p>
